Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials.

Bolenz, Christian; Kunath, Frank; Zengerling, Friedemann; Wezel, Felix; Schmidt, Stefanie; Hartmann, Arndt; Eckstein, Markus

Bolenz, Christian; Kunath, Frank; Zengerling, Friedemann; Wezel, Felix; Schmidt, Stefanie; Hartmann, Arndt; Eckstein, Markus.

Afiliação

Bolenz C; Department of Urology, University of Ulm, Ulm, Germany.
Kunath F; BRIDGE-Consortium e.V, Mannheim, Germany.
Zengerling F; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität, Erlangen, Germany.
Wezel F; UroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Germany.
Schmidt S; BRIDGE-Consortium e.V, Mannheim, Germany.
Hartmann A; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Eckstein M; Department of Urology, University of Ulm, Ulm, Germany.

Urol Int ; 107(5): 480-488, 2023.

Article em En | MEDLINE | ID: mdl-36630942

Assuntos

Carcinoma de Células de Transição; Neoplasias da Bexiga Urinária; Humanos; Neoplasias da Bexiga Urinária/patologia; Carcinoma de Células de Transição/patologia; Medicina de Precisão; Biomarcadores

Palavras-chave

Clinical trials; Neoplasms of the urinary tract; Precision oncology; Tumor biopsy; Urothelial bladder cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google